Global Gastrointestinal Therapeutics Market 2016-2020

Publisher Name :
Date: 30-Sep-2016
No. of pages: 102
Inquire Before Buying

About Gastrointestinal Disorders

Gastrointestinal disorders include both functional and motility disorders affecting the gastrointestinal tract. Functional disorders involve an abnormality in the working of the gastrointestinal tract. They are the most common type of disorders and present with disturbances in motility, visceral hypersensitivity, changes in the mucosal and immune function, variations in central nervous system processing, and altered gut microbiota. Motility disorders are characterized by changes in the movement of the gastrointestinal tract and the transfer of its contents. Some of the most common gastrointestinal functional and motility disorders include IBS, GERD, Crohn's disease, ulcerative colitis, and peptic ulcers.

This analyst forecast the global gastrointestinal therapeutics market to grow at a CAGR of 6.5% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global gastrointestinal therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of various gastrointestinal disorders including IBD, and irritable bowel syndrome (IBS).

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The report, Global Gastrointestinal Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

AbbVie

Johnson & Johnson

Takeda

Allergan

UCB

Other prominent vendors

4SC

Ajinomoto Pharmaceuticals

Alfa Wassermann

Alizyme

Amgen

Anterogen

Ardelyx

Arena Pharmaceuticals

Astellas

AstraZeneca

Astellas Pharma

Avaxia Biologics

Biogen Idec

BioLineRx

Celgene

ChemoCentryx

Cosmo Pharmaceuticals

Drais Pharmaceuticals

Eisai

Eli Lilly

Enlivex Therapeutics

F. Hoffmann-La Roche

Ferring Pharmaceuticals

FF Pharma

Galapagos

Gilead Sciences

GlaxoSmithKline

Hutchison Medi Pharma

Immune Pharmaceuticals

InDex Pharmaceuticals

Ironwood Pharmaceuticals

Kaken Pharmaceutical

Kang Stem Biotech

Kissei Pharmaceutical

Kyowa Hakko Kirin

Lexicon Pharmaceuticals

Lipid Therapeutics

Meda

Merck

Mesoblast

Mitsubishi Tanabe

Mochida Pharmaceutical

Morphotek

Neovacs

Nestle

Norgine

Novartis

Ono Pharmaceutical

Pfizer

Procter & Gamble

Qu Biologics

Receptos

RedHill Biopharma

Salix Pharmaceuticals

Shield Therapeutics

Sterna Biologicals

Synergy Pharmaceuticals

Synthetic Biologics

TiGenix

Tillotts Pharma

TopiVert

TSD Japan

Zeria Pharmaceutical

Market driver

Tentative approval of late stage molecules

For a full, detailed list, view our report

Market challenge

Discontinuation of drugs under development and from the market

For a full, detailed list, view our report

Market trend

Emergence of biosimilars

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Global Gastrointestinal Therapeutics Market 2016-2020

Table of Contents

PART 01:Executive summary
Highlights
PART 02:Scope of the report
Market overview
Top-vendor offerings
PART 03:Market research methodology
Research methodology
Economic indicators
PART 04:Introduction
Key market highlights
PART 05:Pipeline portfolio
Ulcerative colitis
Crohn's disease
IBS
PART 06:Market landscape
Global gastrointestinal therapeutics market
PART 07:Market segmentation by disease type
Overview
PART 08:Global IBD therapeutics market
Global ulcerative colitis drugs market
Global Crohn's disease drugs market
Market segmentation by molecule type
PART 09:Global IBS therapeutics market
PART 10:Global gastrointestinal OTC drugs market
PART 11:Geographical segmentation
Global gastrointestinal therapeutics market by geography 2015-2020
Gastrointestinal therapeutics market in Americas
Gastrointestinal therapeutics market in EMEA
Gastrointestinal therapeutics market in APAC
PART 12:Market drivers
Increasing consumption of biologics
Tentative approval of late stage molecules
Development of novel therapies using innovative technologies
Improved diagnostic tools increasing the treatment-seeking population
PART 13:Impact of drivers
PART 14:Market challenges
Increased consumption of OTC medications
Unknown etiology of IBD and IBS
Discontinuation of drugs under development and from the market
PART 15:Impact of drivers and challenges
PART 16:Market trends
Patient assistance programs
Emergence of biosimilars
Rise in self-medication
Focus on regenerative medicines
Strategic alliances and M&A
PART 17:Vendor landscape
Competitive scenario
Other prominent vendors
PART 18:Key vendor analysis
AbbVie
Johnson & Johnson
Takeda
Allergan
UCB
PART 19:Appendix
List of abbreviations

List of Exhibits

Exhibit 01:Product offerings
Exhibit 02:Global gastrointestinal therapeutics market: Key buying criteria 2015
Exhibit 03:Global gastrointestinal therapeutics market: Key customer segments
Exhibit 04:Global ulcerative colitis therapeutics market: Pipeline portfolio
Exhibit 05:Global Crohn's disease therapeutics market: Pipeline portfolio
Exhibit 06:Global IBS therapeutics market: Pipeline portfolio
Exhibit 07:Global gastrointestinal therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 08:Global gastrointestinal therapeutics market: Factors affecting growth 2015 and 2020
Exhibit 09:Approval and patent expiries of top selling biologics
Exhibit 10:Global gastrointestinal therapeutics market 2016-2020 ($ billions)
Exhibit 11:Global gastrointestinal disorder therapeutics market segmentation: Growth cycle analysis
Exhibit 12:Five forces analysis
Exhibit 13:Global gastrointestinal therapeutics market by disease type: Revenue share 2015
Exhibit 14:Global gastrointestinal therapeutics market by disease type: Growth lifecycle analysis
Exhibit 15:Global gastrointestinal therapeutics market by disease type 2015-2020
Exhibit 16:Global IBD therapeutics market by type: Revenue share 2015
Exhibit 17:Global IBD therapeutics market by type 2015-2020
Exhibit 18:Global IBD therapeutics market segmentation: Growth lifecycle analysis
Exhibit 19:Global ulcerative colitis drugs market 2015-2020 ($ billions)
Exhibit 20:Global Crohn's disease drugs market 2015-2020 ($ billions)
Exhibit 21:Global IBD therapeutics market by molecule type 2015
Exhibit 22:Biologics in global IBD therapeutics market 2015-2020 ($ billions)
Exhibit 23:Small molecules in global IBD therapeutics market 2015-2020 ($ billions)
Exhibit 24:Global IBS therapeutics market 2015-2020 ($ billions)
Exhibit 25:Drugs that underwent Rx-to-OTC switch in the US
Exhibit 26:Global gastrointestinal OTC drugs market 2015-2020 ($ billions)
Exhibit 27:Global gastrointestinal therapeutics market by geography 2015-2020
Exhibit 28:Global gastrointestinal therapeutics market by geography 2015 and 2020
Exhibit 29:Global gastrointestinal therapeutics market by geography 2015-2020 ($ billions)
Exhibit 30:Global gastrointestinal therapeutics market by geography: Market share 2015
Exhibit 31:Global gastrointestinal therapeutics market by geography: Disease type 2015
Exhibit 32:Global gastrointestinal therapeutics market by geography: Market growth lifecycle analysis 2015
Exhibit 33:Global gastrointestinal therapeutics market by country: Revenue and growth rate analysis
Exhibit 34:Opportunity analysis of gastrointestinal therapeutics market in Americas
Exhibit 35:Gastrointestinal therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 36:Opportunity analysis of gastrointestinal therapeutics market in EMEA
Exhibit 37:Gastrointestinal therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 38:Opportunity analysis of gastrointestinal therapeutics market in APAC
Exhibit 39:Gastrointestinal therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 40:Impact of drivers and challenges on global gastrointestinal therapeutics market
Exhibit 41:Biologics for IBD: market share 2012-2022
Exhibit 42:Few biologics under development for gastrointestinal disorders
Exhibit 43:Impact of drivers
Exhibit 44:Rx-to-OTC switch: Promoters and inhibitors
Exhibit 45:Gastrointestinal therapeutics discontinued from development or market
Exhibit 46:Impact of drivers and challenges
Exhibit 47:Global gastrointestinal therapeutics market: Impact assessment of key trends
Exhibit 48:Gastrointestinal therapeutics with patient assistance programs in US
Exhibit 49:Biosimilars under development for gastrointestinal disorders
Exhibit 50:Regenerative medicines for IBD under development
Exhibit 51:Key vendors ranking 2015
Exhibit 52:Key vendors: Geographical presence
Exhibit 53:Market vendors: Competitive scenario 2015-2020
Exhibit 54:AbbVie: Profile
Exhibit 55:AbbVie: Strength analysis
Exhibit 56:AbbVie: Growth strategy matrix
Exhibit 57:AbbVie: Opportunity assessment
Exhibit 58:AbbVie: YoY growth and revenue of HUMIRA 2012-2014 ($ billions)
Exhibit 59:Johnson & Johnson: Profile
Exhibit 60:Johnson & Johnson: Strength analysis
Exhibit 61:Johnson & Johnson: Growth strategy matrix
Exhibit 62:Johnson & Johnson: Opportunity assessment
Exhibit 63:Johnson & Johnson: YoY revenue and growth rate of Remicade 2013-2015 ($ billions)
Exhibit 64:Johnson & Johnson: YoY revenue and growth rate of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 65:Takeda: Profile
Exhibit 66:Takeda: Strength analysis
Exhibit 67:Takeda: Growth strategy matrix
Exhibit 68:Takeda: Opportunity assessment
Exhibit 69:Allergan: Profile
Exhibit 70:Allergan: Strength analysis
Exhibit 71:Allergan: Growth strategy matrix
Exhibit 72:Allergan: Opportunity assessment
Exhibit 73:Allergan: Revenue of gastrointestinal therapeutics 2015 ($ millions)
Exhibit 74:UCB: Profile
Exhibit 75:UCB: Strength analysis
Exhibit 76:UCB: Growth strategy matrix
Exhibit 77:UCB: Opportunity assessment
  • Global Diarrhea Drug Sales Market Report 2017
    Published: 16-Aug-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the global Diarrhea Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diarrhea Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan -......
  • Global Diarrhea Drug Market Research Report 2017
    Published: 09-Aug-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Diarrhea Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Diarrhea Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global and United States Digestive system agents In-Depth Research Report 2017-2022
    Published: 04-Aug-2017        Price: US 3190 Onwards        Pages: 126
    The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2016 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Digestive system agents industry. Major Companies - Sigma-Tau Industrie Farmaceutiche Riunite S.p.A......
  • Global Opioid Induced Constipation Drug Market Forecast 2017-2025
    Published: 01-Aug-2017        Price: US 2500 Onwards        Pages: 113
    Key Findings Global Opioid Induced Constipation (OIC) drug market is estimated to grow at a CAGR of 4.88% during the forecast period of 2017 - 2025. The major drivers responsible for the market growth are: • Rising use of opioid • Increasing geriatric population • Increasing opioid prescription in North America and Europe • Detection of safety threats • Easy availability of improved and effective OIC drugs Some of the commonly prescribed opioids ......
  • Asia-Pacific Opioid Induced Constipation Drug Market Forecast 2017-2025
    Published: 01-Aug-2017        Price: US 1250 Onwards        Pages: 54
    Key Findings The Asia-Pacific Opioid Constipation Drug market is estimated to grow at a CAGR of 5.07% during the forecast period of 2017-2025. The market worth is expected to increase from $233 million in 2016 and reach $361.88 million by 2025. The ease in the availability of new and improved drugs and the growing geriatric population are currently driving the Asian Market. Market Insights The Asian market can be classified on the basis of drug type and prescription type. Th......
  • Europe opioid Induced Constipation Drug Market Forecast 2017-2025
    Published: 01-Aug-2017        Price: US 1250 Onwards        Pages: 52
    Key Findings The Europe opioid constipation drug market is expected to grow at a CAGR of 4.00% during the forecast period of 2017-2025. The market value is predicted to increase from $896.3 million in 2016 and reach up to $1273.34 million by 2025. Market Insights The Europe opioid constipation drug market is mainly driven by the increasing opioids prescription in the region. The market can be segmented into two criteria. First is the market by drug type that includes drugs s......
  • North America Opioid Induced Constipation Drug Market Forecast 2017-2025
    Published: 01-Aug-2017        Price: US 1250 Onwards        Pages: 51
    Key Findings The North America opioid induced constipation drug market is expected to be the fastest growing market during the forecast period of 2017-2025 with an expected CAGR growth of 5.72%. The revenue generated by the market is expected to increase from $840.4 million in 2016 and reach $1382.73 million by 2025. Market Insights The North American OIC drug market is segmented on the basis of the type of prescription and the type of drug. The prescription type market is f......
  • Global Digestive system agents Detailed Analysis Report 2017-2022
    Published: 31-Jul-2017        Price: US 3250 Onwards        Pages: 125
    This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Digestive system agents industry. This report splits Digestive system agents market by Promoting ingestion drugs, by Antispasmodic and gastro-kinetic agent, by Cathartic and antidiarrheal drugs, by Others, which covers the history data information fr......
  • Global Digestive system agents Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
    Published: 31-Jul-2017        Price: US 2380 Onwards        Pages: 115
    The global Digestive system agents market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report offers an overview of the market trends, drivers, and barriers with respect to the Digestive system agents market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs